The Impact of an Innovative eHealth Transition Intervention on Self-Management Skills Among Young Adults With Congenital Heart Disease

Summary

Congenital heart disease (CHD) survivors constitute one of the fastest growing populations in adult cardiology practices. This population is vulnerable to gaps in care, particularly as they graduate from the pediatric to adult healthcare system. Their healthcare needs are complex, and preparing this population for transfer to adult care is a resource-intense process.

This trial will evaluate the use of the MyREADY Transition CHD app against a nurse-led one-time intervention in clinic. Participants will be 16-17 year olds who attend a cardiology outpatient clinic. The app will allow young adults to learn about their heart condition and about self-management skills in the context of adult healthcare by using the app for 18 months. The nurse-led intervention will cover similar topics, but in a one-time in-person session with a clinic nurse.

Outcomes: The primary outcome is change in Transition Readiness Assessment Questionnaire (TRAQ) score over time. Secondary outcomes are change in the MyHeart Score and the General Self-Efficacy (GSE) score. These questionnaires will be answered by all participants at regular intervals (enrollment, 1 month, 6 months, 12 months, 18 months) throughout the trial. The trial will also consider time to the first adult cardiology appointment, cost of the interventions, and will conduct interviews with participants in the app group to learn about their experiences using the app.

Conditions

• Congenital Heart Disease
• Congenital Heart Disease in Adolescence

Interventions

BEHAVIORAL

Use of the CHD app

Use of the CHD app

BEHAVIORAL

Nurse-led intervention

Teaching session with clinic nurse

Sponsors & Collaborators

• McGill University

  collaborator OTHER

• Oregon Health and Science University

  collaborator OTHER

• University of British Columbia

  collaborator OTHER

• University of Toronto

  collaborator OTHER

• Université de Montréal

  collaborator OTHER

• University of Alberta

  lead OTHER

Principal Investigators

• Andrew Mackie · University of Alberta

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

16 Years

Max Age

17 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-01-10

Primary Completion

2025-12-31

Completion

2025-12-31

Countries

• Canada

Study Locations